Trastuzumab beyond progression for HER2 positive metastatic breast cancer: Progression-free survival on first-line therapy predicts overall survival impact
- Daniel Rayson
- , Sarah Lutes
- , Gordon Walsh
- , Marlene Sellon
- , Bruce Colwell
- , Mark Dorreen
- , Arik Drucker
- , Alwin Jeyakumar
- , Tallal Younis
Research output: Contribution to journal › Article › peer-review
14
Link opens in a new tab
Citations
(Scopus)